Richard Storer

8.6k citations

136 papers · 6.2k indexed · 4 hit papers · h-index 33

Co-authors: David W. C. MacMillan Diane E. Carrera Yike Ni Lyn H. Jones C. Aciro Steven V. Ley Francis X. Wilson Philip S. Jackson
Topics: HIV/AIDS drug development and treatment (41 papers)Biochemical and Molecular Research (22 papers)Chemical Synthesis and Analysis (21 papers)
Cited by: Organic Chemistry Virology Inorganic Chemistry
Journals: Journal of the American Chemical Society Chemical Society Reviews Angewandte Chemie International Edition
Partner nations: United Kingdom United States France

In The Last Decade

Richard Storer

129 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enantioselective Organocatalytic Reductive Amination

2005 645 citations Richard Storer et al. profile →
Multi-step organic synthesis using solid-supported reagents and scavengers: a new paradigm in chemical library generation

2000 592 citations Richard Storer et al. profile →
Put a ring on it: application of small aliphatic rings in medicinal chemistry

2021 306 citations Paolo Di Fruscia, Simon C. C. Lucas et al. RSC Medicinal Chemistry profile →
Physiology of Hyperuricemia and Urate-Lowering Treatments

2018 222 citations Richard Storer et al. profile →

Peers

Countries citing papers authored by Richard Storer

Since Specialization

Citations

This map shows the geographic impact of Richard Storer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Storer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Storer more than expected).

Fields of papers citing papers by Richard Storer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Storer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Storer. The network helps show where Richard Storer may publish in the future.

Co-authorship network of co-authors of Richard Storer

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Storer. A scholar is included among the top collaborators of Richard Storer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Storer. Richard Storer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of Pyrimidoindolones as Novel Family VIII Bromodomain Binders 2025 ·ACS Medicinal Chemistry Letters ·Jeffrey A. Boerth,Marianne Schimpl,Simon C. C. Lucas,(unknown),Erin Code,Kevin J. Embrey,Philip B. Rawlins,Haixia Wang,Richard Storer,Paolo Di Fruscia,Jennifer E. Nelson,Alexander G. Milbradt,Ulf Börjesson,Andrea Gohlke,Victoria Korboukh,Ariamala Gopalsamy	0
2	Development of compounds for targeted degradation of mammalian cryptochrome proteins. 2025 ·PubMed ·(unknown),Andrew D. Beale,Iacovos N. Michaelides,Sew‐Yeu Peak‐Chew,Andrei Mihut,Christine T. Styles,(unknown),Richard Storer,Rachel S. Edgar,Kévin Moreau,John S. O’Neill	2
3	Hit me with your best shot: Integrated hit discovery for the next generation of drug targets 2024 ·Drug Discovery Today ·Sajda Ashraf,(unknown),Geoffrey A. Holdgate,Simon C. C. Lucas,(unknown),Richard Storer,Benjamin C. Whitehurst	6
4	Identification of Histone Peptide Binding Specificity and Small-Molecule Ligands for the TRIM33α and TRIM33β Bromodomains 2022 ·ACS Chemical Biology ·(unknown),(unknown),(unknown),(unknown),(unknown),C. Tallant,(unknown),Katarzyna B. Leszczyńska,Rachel L. Grimley,Richard Storer,(unknown),(unknown),Sofia Caria,(unknown),Ester M. Hammond,Stefan Knapp,Garrett M. Morris,Fernanda Duarte,Philip C. Biggin,Stuart J. Conway	13
5	Fragment screening at AstraZeneca: developing the next generation biophysics fragment set 2022 ·RSC Medicinal Chemistry ·Simon C. C. Lucas,Ulf Börjesson,Mark J. Bostock,(unknown),Fredrik Edfeldt,Kevin J. Embrey,Per‐Olof Eriksson,Andrea Gohlke,(unknown),Michael Lainchbury,Alexander G. Milbradt,Rachel Moore,Philip B. Rawlins,Ian Sinclair,C. W. Stubbs,Richard Storer	8
6	Synthesis and functionalisation of a bifunctional normorphan 3D building block for medicinal chemistry 2021 ·Tetrahedron ·(unknown),James R. Donald,James D. Firth,Claudia De Fusco,Richard Storer,Daniel Cox,Peter O’Brien	5
7	Fragment-Based Discovery of Novel Allosteric MEK1 Binders 2021 ·ACS Medicinal Chemistry Letters ·Paolo Di Fruscia,Fredrik Edfeldt,Igor L. Shamovsky,Gavin W. Collie,Anna Aagaard,(unknown),Ulf Börjesson,Eva Hansson,Richard J. Lewis,(unknown),Linda Öster,(unknown),Lena Ripa,Richard Storer,Helena Käck	11
8	Structural Basis for Targeting the Folded P-Loop Conformation of c-MET 2020 ·ACS Medicinal Chemistry Letters ·Gavin W. Collie,Iacovos N. Michaelides,Kevin J. Embrey,Christopher J. Stubbs,Ulf Börjesson,Ian L. Dale,Arjan Snijder,(unknown),Kun Song,(unknown),Christopher Phillips,Richard Storer	15
9	Design and development of histone deacetylase (HDAC) chemical probes for cell-based profiling 2016 ·Molecular BioSystems ·Victoria E. Albrow,Rachel L. Grimley,(unknown),Colin R. Rose,Jianmin Sun,Joseph S. Warmus,Edward W. Tate,Lyn H. Jones,Richard Storer	10
10	A semi-quantitative translational pharmacology analysis to understand the relationship between in vitro ENT1 inhibition and the clinical incidence of dyspnoea and bronchospasm 2016 ·Toxicology and Applied Pharmacology ·(unknown),Richard Storer	13
11	Recent progress in sodium channel modulators for pain 2014 ·Bioorganic & Medicinal Chemistry Letters ·Sharan K. Bagal,Mark L. Chapman,Brian E. Marron,(unknown),Richard Storer,Nigel A. Swain	124
12	Exploiting a novel size exclusion phenomenon for enantioselective acid/base cascade catalysis 2012 ·Chemical Communications ·Michael E. Muratore,Lei Shi,Adam W. Pilling,Richard Storer,Darren J. Dixon	32
13	Topical Nonnucleoside Reverse Transcriptase Inhibitor MC 1220 Partially Prevents Vaginal RT-SHIV Infection of Macaques 2011 ·AIDS Research and Human Retroviruses ·(unknown),Roberta Loddo,Sophia G. Antimisiaris,(unknown),Ulrike Sauermann,(unknown),Spyridon Mourtas,(unknown),Richard Storer,Paolo La Colla,Christiane Stahl‐Hennig	16
14	Squaramides: physical properties, synthesis and applications 2011 ·Chemical Society Reviews ·Richard Storer,C. Aciro,Lyn H. Jones	471
15	6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective α1A adrenoceptor partial agonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·Lee R. Roberts,Paul V. Fish,Richard Storer,Gavin A. Whitlock	13
16	Synthesis of 1′-C-Fluoromethyladenosine 2007 ·Nucleosides Nucleotides & Nucleic Acids ·Annelaure Damont,David Dukhan,Gilles Gosselin,(unknown),Richard Storer	7
17	Synthesis and structure–activity relationship of novel aminotetralin derivatives with high μ selective opioid affinity 2002 ·Bioorganic & Medicinal Chemistry Letters ·Caroline Roy,(unknown),(unknown),(unknown),(unknown),Diane Gagnon,(unknown),Julie Ducharme,Richard Storer,Jean-François Lavallée	7
18	Solution-phase combinatorial chemistry 1998 ·Molecular Diversity ·Diane M. Coe,Richard Storer	7
19	Enzymatic production of optically pure (2′R-cis)-2′-deoxy-3′-thiacytidine (3TC, lamivudine): A potent anti-HIV agent 1993 ·Enzyme and Microbial Technology ·Mahmoud Mahmoudian,B S Baines,(unknown),Richard Hale,Paul D. Jones,(unknown),(unknown),Ian J. Purvis,Richard Storer,Michael J. Dawson,(unknown)	40
20	Penicillin derived C2-symmetric dimers as novel inhibitors of HIV-1 proteinase 1992 ·Journal of Medicinal Chemistry ·David C. Humber,N. Cammack,Jonathan A. Coates,Kevin N. Cobley,David Orr,Richard Storer,Gordon G. Weingarten,Malcolm Weir	26

About Richard Storer

Richard Storer is a scholar working on Virology, Organic Chemistry and Infectious Diseases, having authored 136 papers that have together received 6.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (41 papers), Biochemical and Molecular Research (22 papers) and Chemical Synthesis and Analysis (21 papers). The work is most often cited by research in Organic Chemistry (3.9k citations), Virology (306 citations) and Inorganic Chemistry (837 citations). Richard Storer has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include David W. C. MacMillan, Diane E. Carrera, Yike Ni, Lyn H. Jones, C. Aciro, Steven V. Ley, Francis X. Wilson, Philip S. Jackson, Andrew G. Leach and Darren J. Dixon. Their work appears in journals such as Journal of the American Chemical Society, Chemical Society Reviews and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact